All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

Guidelines and consensus statements ensure that physicians managing acromegaly
patients have access to current information on evidence-based treatments to optimize …

Acromegaly is a chronic systemic disease with many complications and is associated with
increased mortality when not adequately treated. Substantial advances in acromegaly …

Objective: The aim was to formulate clinical practice guidelines for acromegaly. Participants:
The Task Force included a chair selected by the Endocrine Society Clinical Guidelines …

Context: Biochemical control reduces morbidity and increases life expectancy in patients
with acromegaly. With current medical therapies, including the gold standard octreotide long …

Acromegaly is associated with an enhanced mortality, with cardiovascular and respiratory
complications representing not only the most frequent comorbidities but also two of the main …

Abstract Design Valid data on acromegaly incidence, complications and mortality are
scarce. The Danish Health Care System enables nationwide studies with complete follow-up …

Objective To compare the acromegaly mortality rates with those expected for the general
population from studies published before and after 2008. Methods We performed a …

Context: Acromegaly is usually due to the excessive secretion of GH by a pituitary adenoma.
It is frequently accompanied by comorbidities that compromise quality of life and results in …

Objective: It is unclear whether mortality still is increased in acromegaly and whether there
are gender-related differences. We dynamically assessed outcome during long-term follow …